GAIA is focused on the development of evidence-based, safe, and accessible digital therapeutics that help patients restore and maintain their mental and physical health.

With over 20 years of experience and more than 70 products, GAIA has clinically proven effectiveness demonstrated in more than 19 randomized controlled trials (RCTs) and 2 meta-analyses.

Our mission is to develop digital therapeutics that provide physicians, therapists, payers, and patients with effect sizes, safety profiles, and convenience comparable to pharmaceutical solutions.

Our multidisciplinary team includes experienced physicians, psychotherapists, clinical scientists, IT and software engineers, regulatory experts, and market access specialists.

We believe that RCT-evidence is key, which is why our products, such as deprexis®, have been extensively tested in ethical and professionally designed trials.

GAIA AG is a leading company in digital health, combining scientific, technological, and therapeutic expertise. Our partners include pharmaceutical companies, health insurance providers, research organizations, and universities across Europe, USA, and Asia.

GAIA offers a creative, dynamic work environment with short decision-making paths, and the flexibility to work remotely or from their headquarters in Hamburg, Germany.

They provide modern office spaces, healthy working conditions, and an international, innovative team dedicated to improving health worldwide.